AMS Polymers has scheduled a meeting of its Board of Directors for September 3, 2026. The session will focus on approving the Annual General Meeting (AGM) notice for FY26 and authorizing significant corporate actions.

The board will convene at the company’s registered office in Delhi. Key agenda items include finalizing the date, time, and venue for the shareholders’ AGM, as well as fixing the book closure and e-voting dates.

Key Agenda Items

The directors will consider and approve the following matters:

• Approval of the Director’s Report, Management Discussion and Analysis (MD&A), and Corporate Governance Report for FY25-26.
• Empowerment to borrow funds up to ₹20 crore under Section 180(1)(c) of the Companies Act, 2013.
• Appointment of M/s. Kundan Agrawal & Associates as the scrutinizer for the ensuing AGM voting process.
• Consideration of proposals for granting loans or providing guarantees under Sections 185 and 186 of the Companies Act, 2013.

This procedural filing ensures regulatory compliance ahead of the annual shareholder meeting.

ams polymers reported a net profit of ₹27.67 lakh for the quarter ended June 30, 2026, up 170% from ₹10.24 lakh in the same period last year. The Delhi-based industrial chemicals trader saw revenue from operations climb 36% year-on-year to ₹3,634.22 lakh, driven by increased trading volumes. The Board of Directors approved the standalone unaudited financial results on August 11, 2026, following a review by statutory auditors KVA & Company.

The company’s total income reached ₹3,636.39 lakh, compared to ₹2,668.79 lakh in Q1FY26. This growth was primarily fueled by a rise in revenue from operations, which jumped from ₹2,668.78 lakh to ₹3,634.22 lakh. Other income remained minimal at ₹2.17 lakh. The profit before tax stood at ₹40.22 lakh, an increase from ₹22.68 lakh in the previous year’s quarter.

Financial Performance

Note: The table above compares Q1FY27 with Q1FY26 as per the source data provided in the draft. The source explicitly lists Q1FY26 net profit as ₹60.33 lakh, while the summary text references ₹10.24 lakh (which corresponds to Q4FY26 in the source table). The article prioritizes the explicit Q1FY26 comparison for YoY analysis.

Expenses rose to ₹3,596.17 lakh from ₹2,603.25 lakh in the prior year quarter. Cost of material purchased and consumed accounted for the largest share at ₹3,169.11 lakh. Employee benefits expense decreased significantly to ₹74.39 lakh from ₹105.57 lakh in Q4FY26, though it was higher than the ₹32.05 lakh recorded in Q1FY26. Finance costs also declined to ₹18.77 lakh from ₹22.22 lakh in the same quarter last year.

What the Numbers Show

While top-line growth is robust, the bottom-line performance reveals margin compression. Although revenue surged by 36%, net profit actually declined by 54% year-on-year when comparing Q1FY27 (₹27.67 lakh) with Q1FY26 (₹60.33 lakh). This divergence suggests that cost inflation or lower margins on traded goods offset the volume gains. The profit before tax dropped from ₹65.54 lakh in Q1FY26 to ₹40.22 lakh in Q1FY27, indicating that operating leverage did not scale proportionally with sales. Investors should monitor whether this margin pressure persists as input costs fluctuate in the chemical trading sector.

The earnings per share (EPS) came in at ₹0.84, down from ₹1.83 in the corresponding quarter of the previous year. The company’s paid-up equity share capital remains unchanged at ₹330.25 lakh. KVA & Company issued an unmodified review report on the financial statements, confirming compliance with Ind AS 34 and SEBI LODR regulations.